Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.0550 (-4.67%) ($8.0550 - $8.0550) on Fri. Apr. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.01% (three month average) | RSI | 39 | Latest Price | $8.0550(-4.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.4% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(31%) CEMB(25%) XLRE(24%) BND(22%) BWX(21%) | Factors Impacting BCRX price | BCRX will decline at least -1.505% in a week (0% probabilities). VIXM(-19%) VXX(-17%) UUP(-12%) TLT(-9%) VCIT(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.505% (StdDev 3.01%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.35 | 5 Day Moving Average | $8.38(-3.88%) | 10 Day Moving Average | $8.4(-4.11%) | 20 Day Moving Average | $8.35(-3.53%) | To recent high | -27.5% | To recent low | 1.6% | Market Cap | $1.421b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |